Nyxoah (NYXH) announced that the FDA has approved the Genio system for a subset of patients with moderate to severe OSA with an Apnea-Hypopnea Index of greater than or equal to 15 and less than or equal to 65.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NYXH: